SucraidASSIST™- Comprehensive Patient Support Program (HCP)


Patient Support

SucraidASSIST™ Program

The SucraidASSIST program is provided by QOL Medical, LLC and offers patient support services for patients diagnosed with Congenital Sucrase-Isomaltase Deficiency (CSID), their caregivers, and healthcare providers. The SucraidASSIST program is the source for information regarding drug and disease education, diet resources, and daily living for patients taking Sucraid®.

SucraidASSIST Patient Support Program

SucraidASSIST (“Access and Support Services in Sucraid® Therapy”) is a comprehensive program of support, education, and financial assistance services for eligible U.S. patients with Congenital Sucrase-Isomaltase Deficiency (CSID). SucraidASSIST is staffed by dedicated Sucraid® specialists who are available to answer all Sucraid®-related questions.

The first point of contact in SucraidASSIST is through our patient care coordinators, who provide the following services:

  • Serve as the single point-of-contact for all SucraidASSIST patient support services
  • Assess and triage referred patients to the appropriate SucraidASSIST professionals
  • Obtain authorization and consent for referral of patients to optional support services
  • Follow-up periodically with current Sucraid® patients to assess their satisfaction with therapy
  • Contact patients who discontinue therapy for rescue attempts/referral to services as needed
Dedicated Sucraid® Specialists
  • Provide support and education
  • Primary point of contact
Financial Assistance for Sucraid® Patients
  • Copay assistance may be available
  • Deductible and premium support
Insurance Coverage Assessment
  • Prior authorization assistance
  • Most plans cover Sucraid®
Medicaid/Medicare Appeal Support
  • Assistance with an appeal of Medicaid and Medicare plans if coverage for Sucraid® is initially denied
Nutritional Support
  • Resources for diet management

To Enroll in the SucraidASSIST Program

Electronic Enrollment

Click the link below to complete the form and electronically enroll in the SucraidASSIST program.

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Do not use Sucraid® (sacrosidase) Oral Solution with patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light.


Sucraid®(sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of Congenital Sucrase-Isomaltase Deficiency (CSID).